Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Share-based Compensation (2016 - 2026)

Myriad Genetics has reported Share-based Compensation over the past 17 years, most recently at $2.8 million for Q4 2025.

  • Quarterly Share-based Compensation fell 74.31% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.2 million through Dec 2025, down 29.32% year-over-year, with the annual reading at $35.2 million for FY2025, 29.32% down from the prior year.
  • Share-based Compensation was $2.8 million for Q4 2025 at Myriad Genetics, down from $12.2 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $14.5 million in Q2 2024 and troughed at $2.8 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $10.2 million (2022), against an average of $10.0 million.
  • Year-over-year, Share-based Compensation skyrocketed 60.0% in 2024 and then tumbled 74.31% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $8.4 million in 2021, then dropped by 2.38% to $8.2 million in 2022, then rose by 26.83% to $10.4 million in 2023, then grew by 4.81% to $10.9 million in 2024, then tumbled by 74.31% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Share-based Compensation are $2.8 million (Q4 2025), $12.2 million (Q3 2025), and $10.7 million (Q2 2025).